1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin,2005,55(2) :74 - 108. 被引量：1
2Sungij, Laujy, Gohkl, et al. Increasing incidence of colorectal cancer in Asia: implications for screening [ J ], Lancet Oncol, 2005, 6(1l) : 871 -876. 被引量：1
3Sugano K, Ushiama M, Fulentomi T, et al. Combinated detection af C -erbB -2 protein in breast cancer tissues and the serum of the l/u- man with breast cancer[J]. Int Jcancer,2000, 89:329 -336. 被引量：1
4Shih C, Padhy LC, Murray M, et al. Transforming genes of carci- nomas and neuroblastomas as introduced into mouse fibroblasts [J]. Nature,1981,290:261 -264. 被引量：1
5Semba K, Kamata N, Toyoshima K, et al. A VerbB -related pro- tooncogene, c - erbB - 2, is distinct from the c - erbB - 1/epider- mal growth factor - receptor gene and is amplified in a human sati- vary gland adenocarcinoma[ J]. Prec Natl Acad Sci USA, 1985, 82 (19) : 6497 - 6501. 被引量：1
6Coussens L, Yang- Feng TL, LiaoTc, et al. Tyrosine Kinase re- ceptor with extensive homology to EGF receptor share chromosomal location with neuoncogene[ J ]. Science, 1985, 230 : 1132 - 1139. 被引量：1
7Schechter AL, Hung MC, Vaidyanathan L, et al. The neu gene: an erbB - homologous gene distinct from and unlinked to the gene encoding the EGF receptor[ J ]. Science, 1985,229 ( 4717 ) : 976 - 978. 被引量：1
8Tiseo M, Loprevite M, Ardizzoni A. Epidermal growth factor re- ceptor inhibitors: a new prospective in the treatment of lung cancer [J]. Curt Med Chem Anticancer Agents,2004, 4(2) : 139 - 148. 被引量：1
9Press MF, Finn RS, Cameron D, et al. HER -2 gene amplifica- tion, HER -2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer[ J ]. Clin Cancer Res,2008, 14 (23) : 7861 - 7870. 被引量：1
10Iivanainen E, Nelimarkka L, Elenius V, et al. Angiopoietin - regulated recruitment of vascular smooth muscle cells by endothe- lial - derived heparin binding EGF - like growth factor [ J ]. FASEB J,2003, 17(12) : 1609 - 1621. 被引量：1
4Arteaga CL, Moulder SL, Yakes FM. HER (erb)B) tyrosine kinase inhibitors in the treatment of breasl cancer[J]. Semin Oncol, 2002,29(11) : 4 - 10. 被引量：1
5Raxevanis CN, Sotiropoulou PA, Sotiriadou NN, et al. Immunobiology of IIER-2/neu oneoprotein and its potential application in cancer immunotherapy[ J ]. Cancer Immunol Immunother, 2004, 53(3): 166 - 175. 被引量：1
6Kapitanovic S, Radoscvic S, Kapitanovic M, et al.The expression of p185 (HER-2/neu) corrclates with the stage of diseasc and survival in colorectal cancer [ J ], Castroenterology, 1997, 112(4) :1103 -1113. 被引量：1
7Gerdes J,Lemke H,Baisch H,et al.Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoelonal antibody Ki67[J].J Immunol,1994,133(1):710-716. 被引量：1
8Urruticoechca A, Smith IE, Dowsett M, et al. Proliferation marker Ki-67 in early breast cancer [ J ]. J Clin Oncol, 2005.23 (28) : 7212 - 7220. 被引量：1
9Kuniyasu H,Ove N, Shiqeishi,et al. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis[ J ]. J Exp Clin Cancer Res, 2001,20 (4) :543 -548. 被引量：1
10Singleton TP, Strickler JG. Clinical and pathologic significance of the C-erbB-2(Her-2/neu) oneogene [ J 1 , Pathol Annu, 1992,27 : 165 - 190. 被引量：1
5Slamon D, Eiermann W, Robert N, et al. Adjuvant Trastuzumab in HER2 - Positive ,Breast Cancer [ J ]. N Engl J Med, 2011,365 ( 14 ) : 1273 - 1283. 被引量：1
6Bertotti A, Migliardi G, Galimi F, et al. A molecularly annotated plat- form of patient - derived xenografts ( " xenopatients" ) identifies HER2 as an effectivetherapeutic target in cetuximab - resistant 'colorectal canc- er[J]. Cancer Discov, 2011, 1 (6) :508 -523. 被引量：1
7Nazemalhosseini Mojarad E, Kuppen PJ HER2 and immunotherapy u- sing monoclonal antibodies in colorectal cancer [ J ]. Irmnunotherapy, 2013,5 (12) : 1267 - 1269. 被引量：1
8Hofmann M, Stoss O, Shi D, ,et al. Assessment of a HER3 scoring sys-tem for gastric cancer: results from a validation study [J].Histopathology, 2008,52(7) :797 -805. 被引量：1
9Li C, Liu DR, Ye LY, et hi. HER- 2 overexpression and survival incolorectal cancer: a meta - analysis[ J.]J Zhejiang ,Univ Sci B, 2014,15(6):582 -589. 被引量：1
